National Cancer Institute U.S. National Institutes of Healthwww.cancer.gov
Osteoporosis Prevention logo Osteoporosis Prevention after Surgical Menopause

Risks and Benefits of Study Participation

Is there any risk to me?

Zometa® may cause flu-like symptoms, nausea and fatigue, symptoms that usually resolve on their own after a day or two. Some less common side effects include coughing, rash, or headaches. There is also a possibility of an allergic reaction. There have also been rare instances of kidney problems and dental problems associated with Zometa® use. You should thoroughly discuss the possible side effects of this or any treatment with your doctor before making a decision about participating in this study or about what type of treatment you will receive.

What are the benefits to me?

You will receive regular bone density scans and regular follow-up to assess bone health at no charge during this study. Although no direct benefits to your bone health are known at this time, we do know that the information from this study will help doctors learn more about zoledronic acid and its impact on preventing bone loss. This information could help women in the future who undergo menopause.

 

Home
Study Brochure
Study Eligibility
Risks
How to Participate
Non-Hormonal Options
Related Study - Ovarian Cancer Prevention GOG199

This page has links to PDF files. Download Adobe Acrobat® Reader™ to view PDF files.

National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov